Highmark Inc. released results from the company’s Quality Blue Hospital Pay for Performance program that demonstrates clinical outcome improvements by hospitals in Western and Central Pennsylvania and West Virginia in many different areas. The year over year improvements demonstrates that the program has been successful.
One of the improvements during the past year related to infection prevention. The Quality Blue Hospital Pay for Performance Program has focused on reducing and eliminating hospital infections. Central line-associated bloodstream infections (CLABSI)occurred at lower rate at hospitals that participated in the Quality Blue program than national rates based on infection ratesdocumented by the Centers for Disease Control and Prevention (CDC).
As a result, Highmark Quality Blue hospitals have experienced 1853 fewer CLABSI than what would be expected at the national rate. With mortality rates between 12-25 percent for these adverse events, this represents a potential 222-463 fewer deaths compared to the national rate.
During the past year 102 hospitals in Pennsylvania and West Virginia participated in the Quality Blue Hospital Pay for Performance program. Together with the Quality Blue Patient-Centered Medical home (PCMH) program and the Quality Blue Accountable Care Alliance (ACA) Program, Highmark will continue to emphasize ways to support hospitals and physicians as they improve quality and patient safety while lowering health care costs.
PRNewswire, Nov. 6, 2013
- November 6, 2013
- Posted by webmin